Impact of Promising Biomarkers on Severity and Outcome of Acute Pulmonary Embolism

References

• Blondon M, Jimenez D, Robert‐Ebadi H, et al. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: a registry‐based cohort study. J Thromb Haemost. 2021;19:408–416. doi:10.1111/jth.15146
   PubMed Web of Science ®Google Scholar
• Gupta R, Ammari Z, Dasa O, et al. Long-term mortality after massive, submassive, and low-risk pulmonary embolism. Vasc Med. 2020;25:141–149. doi:10.1177/1358863X19886374
   PubMed Web of Science ®Google Scholar
• Qian H-Y, Huang J, Yang Y-J, et al. Heart-type fatty acid binding protein in the assessment of acute pulmonary embolism. Am J Med Sci. 2016;352:557–562. doi:10.1016/j.amjms.2016.08.018
   PubMed Web of Science ®Google Scholar
• Innocenti F, Lazzari C, Ricci F, Paolucci E, Agishev I, Pini R. D-dimer tests in the emergency department: current insights. Open Access Emerg Med. 2021;13:465–479. doi:10.2147/OAEM.S238696
   PubMed Web of Science ®Google Scholar
• Andresen M, González A, Mercado M, et al. Natriuretic peptide type-B can be a marker of reperfusion in patients with pulmonary thromboembolism subjected to invasive treatment. Int J Cardiovasc Imaging. 2012;28:659–666. doi:10.1007/s10554-011-9857-7
   PubMed Web of Science ®Google Scholar
• Vuilleumier N, Le Gal G, Verschuren F, et al. Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study. J Thromb Haemost. 2009;7:391–398. doi:10.1111/j.1538-7836.2008.03260.x
   PubMed Web of Science ®Google Scholar
• Liu X, Zheng L, Han J, et al. Joint analysis of D-dimer, N-terminal pro b-type natriuretic peptide, and cardiac troponin I on predicting acute pulmonary embolism relapse and mortality. Sci Rep. 2021;11:14909. doi:10.1038/s41598-021-94346-7
   PubMed Web of Science ®Google Scholar
• Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ. 2020;370:m2177. doi:10.1136/bmj.m2177
   PubMedGoogle Scholar
• Seropian IM, Chiabrando JG, Damonte JI, et al. Prognosis of patients with acute pulmonary embolism and discordant right ventricle strain serum biomarkers. Int J Cardiol. 2021;340:88–93. doi:10.1016/j.ijcard.2021.08.032
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14. doi:10.1016/j.echo.2014.10.003
   PubMed Web of Science ®Google Scholar
• Dursunoglu N, Dursunoglu D, Yildiz AI, Rota S. Evaluation of cardiac biomarkers and right ventricular dysfunction in patients with acute pulmonary embolism. Anadolu Kardiyol Dergisi/The Anatol J Cardiol. 2014. doi:10.5152/akd.2014.5828
   Google Scholar
• Kaczyñska A, Pelsers MMAL, Bochowicz A, et al. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta. 2006;371:117–123. doi:10.1016/j.cca.2006.02.032
   PubMed Web of Science ®Google Scholar
• Bi W, Liang S, He Z, et al. The Prognostic Value of the Serum Levels of Brain Natriuretic Peptide, Troponin I, and D-Dimer, in Addition to the Neutrophil-to-Lymphocyte Ratio, for the Disease Evaluation of Patients with Acute Pulmonary Embolism. Int J Gen Med. 2021;14:303–308. doi:10.2147/IJGM.S288975
   PubMed Web of Science ®Google Scholar
• Naito A, Tanabe N, Jujo T, et al. Pentraxin3 in Chronic Thromboembolic Pulmonary Hypertension: a New Biomarker for Screening from Remitted Pulmonary Thromboembolism. PLoS One. 2014;9:e113086. doi:10.1371/journal.pone.0113086
   PubMed Web of Science ®Google Scholar
• Jenab Y, Pourjafari M, Sotoudeh M, et al. Comparing the effect of cardiac biomarkers on the outcome of normotensive patients with acute pulmonary embolism. Monaldi Arch Chest Dis. 2017;87. doi:10.4081/monaldi.2017.767
   PubMedGoogle Scholar
• Vuilleumier N, Righini M, Perrier A, et al. Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism. Thromb Res. 2008;121:617–624. doi:10.1016/j.thromres.2007.07.003
   PubMed Web of Science ®Google Scholar
• Lankeit M, Kempf T, Dellas C, et al. Growth Differentiation Factor-15 for Prognostic Assessment of Patients with Acute Pulmonary Embolism. Am J Respir Crit Care Med. 2008;177:1018–1025. doi:10.1164/rccm.200712-1786OC
   PubMed Web of Science ®Google Scholar
• Duran L, Kayhan S, Guzel A, et al. The Prognostic Values of GDF-15 in Comparison with NT-proBNP in Patients with Normotensive Acute Pulmonary Embolism. Clin Lab. 2014;60. doi:10.7754/Clin.Lab.2013.130827
   Web of Science ®Google Scholar
• Liu M, Yuan X, Qiu X, et al. Prognostic Role of Heart-type Fatty Acid Binding Protein in Pulmonary Embolism: a Meta-analysis. Thromb Res. 2015;135:20–25. doi:10.1016/j.thromres.2014.10.007
   PubMed Web of Science ®Google Scholar
• Pruszczyk P, Bochowicz A, Kostrubiec M, et al. Myoglobin stratifies short-term risk in acute major pulmonary embolism. Clin Chim Acta. 2003;338:53–56. doi:10.1016/j.cccn.2003.07.017
   PubMed Web of Science ®Google Scholar
• Bonfanti L, Cervellin G, Calamai S, et al. Diagnostic significance of combining d-dimer with high-sensitivity cardiac troponin I for improving the diagnosis of venous thromboembolism in the emergency department. Acta Biomed. 2021;92. doi:10.23750/abm.v92i5.9752
   Google Scholar
• Skowrońska M, Skrzyńska M, Machowski M, et al. Usefulness of GDF-15 concentrations in plasma in prognosing serious adverse events and bleeding in acute pulmonary embolism: a prospective observational study. Polish Arch Intern Med. 2020. doi:10.20452/pamw.15515
   PubMedGoogle Scholar